CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,266,331 | +234.1% | 108,326 | +8.1% | 0.03% | -18.9% |
Q3 2018 | $379,000 | +44.1% | 100,181 | +19.0% | 0.04% | +60.9% |
Q2 2018 | $263,000 | -10.5% | 84,181 | -31.6% | 0.02% | -34.3% |
Q1 2018 | $294,000 | +54.7% | 123,000 | +78.3% | 0.04% | -12.5% |
Q2 2017 | $190,000 | -28.3% | 68,970 | -49.2% | 0.04% | -18.4% |
Q1 2017 | $265,000 | +173.2% | 135,872 | +242.3% | 0.05% | +14.0% |
Q4 2015 | $97,000 | -49.2% | 39,695 | -37.7% | 0.04% | -52.7% |
Q3 2015 | $191,000 | – | 63,667 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |